GERN Q3 2025 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$47M+67.1% YoY

Gross Profit

$25M53.2% margin

Operating Income

-$14M-29.4% margin

Net Income

-$18M-39.0% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

-3.7%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$13M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$567M

Total Liabilities

$319M

Stockholders' Equity

$249M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$47M	$28M	+67.1%
Gross Profit	$25M	$28M	-9.7%
Operating Income	-$14M	-$28M	+50.8%
Net Income	-$18M	-$26M	+30.3%

Revenue Segments

Revenues Before Adjustments

$60M56%

Product

$47M44%